Systemic inflammatory responses in progressing periodontitis during pregnancy in a baboon model

Clinical and Experimental Immunology

Volumn 162, Issue 3, 2010, Pages 550-559

  Ebersole, J L ^a   Steffen, M J ^a   Holt, S C ^b   Kesavalu, L ^c   Chu, L ^d   Cappelli, D ^d  

^a UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

^b FORSYTH INSTITUTE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Antibody; Baboons; Inflammation; Periodontitis; Pregnancy

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; ACUTE PHASE PROTEIN; ANTIMICROBIAL CATIONIC PEPTIDE; AUTACOID; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; BACTERIUM ANTIBODY; CARRIER PROTEIN; CYTOKINE; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN; PLASMA PROTEIN;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BABOON; BLEEDING; CAMPYLOBACTER RECTUS; CONTROLLED STUDY; DELIVERY; DISEASE COURSE; DISEASE SEVERITY; EXPERIMENTAL ANIMAL; FEMALE; FUSOBACTERIUM NUCLEATUM; GINGIVITIS; HYPOTHESIS; LIGATION; NEEDLE; NONHUMAN; PERIODONTITIS; PLAQUE FORMING CELL; PORPHYROMONAS GINGIVALIS; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SERUM BACTERICIDAL ACTIVITY; STRATIFICATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T LYMPHOCYTE; ANIMAL; BLOOD; DISEASE MODEL; IMMUNOLOGY; PATHOPHYSIOLOGY; PERIODONTICS; PREGNANCY COMPLICATION;

ACUTE-PHASE PROTEINS; ANIMALS; ANTIBODIES, BACTERIAL; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; CARRIER PROTEINS; CYTOKINES; DINOPROSTONE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GINGIVITIS; IMMUNOGLOBULIN G; INFLAMMATION MEDIATORS; LIGATION; MEMBRANE GLYCOPROTEINS; PAPIO; PERIODONTAL INDEX; PERIODONTITIS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 79952473015     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04202.x     Document Type: Article

References (59)

1. Gruys E, Toussaint MJ, Niewold TA, Koopmans SJ, van Dijk E, Meloen RH. Monitoring health by values of acute phase proteins. Acta Histochem 2006; 108:229-32.
2. Ebersole JL, Cappelli D. Acute-phase reactants in infections and inflammatory diseases. Periodontol 2000 2000; 23:19-49.
3. Nibali L, D'Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS. Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study. J Clin Periodontol 2007; 34:931-7.
4. Orozco A, Gemmell E, Bickel M, Seymour GJ. Interleukin-1beta, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis. Oral Microbiol Immunol 2006; 21:256-60.
5. Yamazaki K, Honda T, Oda T et al. Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodontal Res 2005; 40:53-8.
6. Nibali L, Tonetti MS, Ready D et al. Interleukin-6 polymorphisms are associated with pathogenic bacteria in subjects with periodontitis. J Periodontol 2008; 79:677-83.
7. Godbout JP, Glaser R. Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer. J Neuroimmune Pharmacol 2006; 1:421-7.
8. Nylen S, Sacks D. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 2007; 28:378-84.
9. Clark IA. How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev 2007; 18:335-43.
10. Ng PC, Lam HS. Diagnostic markers for neonatal sepsis. Curr Opin Pediatr 2006; 18:125-31.
11. Pussinen PJ, Paju S, Mantyla P, Sorsa T. Serum microbial- and host-derived markers of periodontal diseases: a review. Curr Med Chem 2007; 14:2402-12.
12. Tatakis DN, Kumar PS. Etiology and pathogenesis of periodontal diseases. Dent Clin North Am 2005; 49:491-516.
13. Kinane DF, Bartold PM. Clinical relevance of the host responses of periodontitis. Periodontol 2000 2007; 43:278-93.
14. Seymour GJ, Ford PJ, Cullinan MP, Leishman S, Yamazaki K. Relationship between periodontal infections and systemic disease. Clin Microbiol Infect 2007; 13 (Suppl. 4):3-10.
15. Kamer AR, Craig RG, Dasanayake AP, Brys M, Glodzik-Sobanska L, de Leon MJ. Inflammation and Alzheimer's disease: possible role of periodontal diseases. Alzheimers Dement 2008; 4:242-50.
16. Farasat S, Aksentijevich I, Toro JR. Autoinflammatory diseases: clinical and genetic advances. Arch Dermatol 2008; 144:392-402.
17. Bistrian B. Systemic response to inflammation. Nutr Rev 2007; 65:S170-2.
18. Craig RG. Interactions between chronic renal disease and periodontal disease. Oral Dis 2008; 14:1-7.
19. Church LD, Cook GP, McDermott M. Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol 2008; 4:34-42.
20. Wouters EF, Groenewegen KH, Dentener MA, Vernooy JH. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc Am Thorac Soc 2007; 4:626-34.
21. Sacre SM, Drexler SK, Andreakos E, Feldmann M, Brennan FM, Foxwell BM. Could Toll-like receptors provide a missing link in chronic inflammation in rheumatoid arthritis? Lessons from a study on human rheumatoid tissue. Ann Rheum Dis 2007; 66 (Suppl. 3):iii81-6.
22. Kumagai Y, Takeuchi O, Akira S. Pathogen recognition by innate receptors. J Infect Chemother 2008; 14:86-92.
23. Hisamatsu T, Ogata H, Hibi T. Innate immunity in inflammatory bowel disease: state of the art. Curr Opin Gastroenterol 2008; 24:448-54.
24. Meyer T, Stockfleth E. Clinical investigations of Toll-like receptor agonists. Expert Opin Investig Drugs 2008; 17:1051-65.
25. Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 2008; 3:352-63.
26. Boggess KA. Pathophysiology of preterm birth: emerging concepts of maternal infection. Clin Perinatol 2005; 32:561-9.
27. Nygren P, Fu R, Freeman M, Bougatsos C, Klebanoff M, Guise JM. Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: an update review for the U.S. Preventive Services Task Force. Ann Intern Med 2008; 148:220-33.
28. Guaschino S, De Seta F, Piccoli M, Maso G, Alberico S. Aetiology of preterm labour: bacterial vaginosis. Br J Obstet Gynaecol 2006; 113 (Suppl. 3):46-51.
29. Hansen-Pupp I, Hallin AL, Hellstrom-Westas L et al. Inflammation at birth is associated with subnormal development in very preterm infants. Pediatr Res 2008; 64:183-8.
30. Blank V, Hirsch E, Challis JR, Romero R, Lye SJ. Cytokine signaling, inflammation, innate immunity and preterm labour - a workshop report. Placenta 2008; 29S:102-4.
31. Shoji T, Yoshida S, Mitsunari M et al. Involvement of p38 MAP kinase in lipopolysaccharide-induced production of pro- and anti-inflammatory cytokines and prostaglandin E(2) in human choriodecidua. J Reprod Immunol 2007; 75:82-90.
32. Romero R, Gotsch F, Pineles B, Kusanovic JP. Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 2007; 65:S194-202.
33. Lee SE, Romero R, Jung H, Park CW, Park JS, Yoon BH. The intensity of the fetal inflammatory response in intraamniotic inflammation with and without microbial invasion of the amniotic cavity. Am J Obstet Gynecol 2007; 197:294 e1-6.
34. Menon R, Fortunato SJ. Infection and the role of inflammation in preterm premature rupture of the membranes. Best Pract Res Clin Obstet Gynaecol 2007; 21:467-78.
35. Tornblom SA, Klimaviciute A, Bystrom B, Chromek M, Brauner A, Ekman-Ordeberg G. Non-infected preterm parturition is related to increased concentrations of IL-6, IL-8 and MCP-1 in human cervix. Reprod Biol Endocrinol 2005; 3:39.
36. Timmerman MF, van der Weijden GA. Risk factors for periodontitis. Int J Dent Hyg 2006; 4:2-7.
37. Teles RP, Haffajee AD, Socransky SS. Microbiological goals of periodontal therapy. Periodontol 2000 2006; 42:180-218.
38. Van Dyke TE, Sheilesh D. Risk factors for periodontitis. J Int Acad Periodontol 2005; 7:3-7.
39. Ebersole JL. Humoral immune responses in gingival crevice fluid: local and systemic implications. Periodontol 2000 2003; 31:135-66.
40. Ebersole JL, Taubman MA. The protective nature of host responses in periodontal diseases. Periodontol 2000 1994; 5:112-41.
41. Ebersole JL, Cappelli D, Holt SC. Periodontal diseases: to protect or not to protect is the question? Acta Odontol Scand 2001; 59:161-6.
42. Ebersole JL. Immune responses in periodontal diseases. In: Wilson TG Jr, Kornman KS, eds. Fundamentals of periodontics. Chicago: Quintessence Publishing Co., Inc., 2003:111-43.
43. Offenbacher S, Boggess KA, Murtha AP et al. Progressive periodontal disease and risk of very preterm delivery. Obstet Gynecol 2006; 107:29-36.
44. Boggess KA, Beck JD, Murtha AP, Moss K, Offenbacher S. Maternal periodontal disease in early pregnancy and risk for a small-for-gestational-age infant. Am J Obstet Gynecol 2006; 194:1316-22.
45. Boggess KA. Pathogenicity of periodontal pathogens during pregnancy. Am J Obstet Gynecol 2005; 193:311-12.
46. Cappelli D, Steffen MJ, Holt SC, Ebersole JL. Periodontitis in pregnancy: clinical and serum antibody observations from a baboon model of ligature-induced disease. J Periodontol 2009; 80:1154-65.
47. Cappelli D, Holt SC, Singer RE, Pickrum HM, Ebersole J. Effects of 0·12% chlorhexidine gluconate on experimental gingivitis in non-human primates: clinical and microbiological alterations. Oral Dis 2000; 6:124-31.
48. Reynolds MA, Dawson DR, Novak KF et al. Effects of caloric restriction on inflammatory periodontal disease. Nutrition 2009; 25:88-97.
49. Ebersole JL, Cappelli D, Holt SC, Singer RE, Filloon T. Gingival crevicular fluid inflammatory mediators and bacteriology of gingivitis in nonhuman primates related to susceptibility to periodontitis. Oral Microbiol Immunol 2000; 15:19-26.
50. Kornman KS, Holt SC, Robertson PB. The microbiology of ligature-induced periodontitis in the cynomolgus monkey. J Periodont Res 1981; 16:363-71.
51. Ebersole JL, Cappelli D, Steffen MJ. Characteristics and utilization of antibody measurements in clinical studies of periodontal disease. J Periodontol 1992; 63:1110-16.
52. Ebersole JL, Kornman KS. Systemic antibody responses to oral microorganisms in the cynomolgus monkey: development of methodology and longitudinal responses during ligature-induced disease. Res Immunol 1991; 142:829-39.
53. Ebersole JL, Steffen MJ, Gonzalez-Martinez J, Novak MJ. Effects of age and oral disease on systemic inflammatory and immune parameters in nonhuman primates. Clin Vaccine Immunol 2008; 15:1067-75.
54. Ebersole JL, Cappelli D, Mathys EC et al. Periodontitis in humans and non-human primates: oral-systemic linkage inducing acute phase proteins. Ann Periodontol 2002; 7:102-11.
55. Ebersole JL, Steffen MJ, Reynolds MA et al. Differential gender effects of a reduced-calorie diet on systemic inflammatory and immune parameters in nonhuman primates. J Periodont Res 2008; 43:500-7.
56. Moritz AJ, Cappelli D, Lantz MS, Holt SC, Ebersole JL. Immunization with Porphyromonas gingivalis cysteine protease: effects on experimental gingivitis and ligature-induced periodontitis in Macaca fascicularis. J Periodontol 1998; 69:686-97.
57. Holt SC, Ebersole J, Felton J, Brunsvold M, Kornman KS. Implantation of Bacteroides gingivalis in nonhuman primates initiates progression of periodontitis. Science 1988; 239:55-7.
58. Ebersole JL, Holt SC, Hansard R, Novak MJ. Microbiologic and immunologic characteristics of periodontal disease in Hispanic Americans with type 2 diabetes. J Periodontol 2008; 79:637-46.
59. Kinane DF, Podmore M, Murray MC, Hodge PJ, Ebersole J. Etiopathogenesis of periodontitis in children and adolescents. Periodontol 2000 2001; 26:54-91.